Scientists see GLP-1 agonist drugs as a breakthrough due to their impact on the brain's regulation of hormones, digestion, and hunger, showing promise in preventing breast, colon, liver, and ovarian cancers.
Research indicates that GLP-1 drugs may reduce the risk of colon cancer even in non-overweight individuals and provide more protection against cancer for diabetic patients than insulin treatments.
Studies suggest that both bariatric surgery and GLP-1 medications significantly reduce the risk of obesity-related cancers, with GLP-1 drugs leading to a 39% risk reduction, representing a notable advancement.
#glp-1-agonist-drugs #cancer-prevention #obesity-related-cancers #diabetes-treatment #bariatric-surgery
[
Collection
]
[
|
...
]